Menu Back toLS39: Utilization method of electronic data submitted for J-NDA filing

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS39: Utilization method of electronic data submitted for J-NDA filing

Session Chair(s)

Natsuko  Hamada

Natsuko Hamada

  • Senior Regulatory Scientist, Therapeutic Area Regulatory,
  • Eli Lilly Japan K.K., Japan

Speaker(s)

Daisuke  Iwata

Daisuke Iwata

  • Office of Advanced Evaluation with Electronic Data
  • Pharmaceuticals and Medical Devices Agency, Japan
Masayuki  Tagami

Masayuki Tagami

  • Manager, Regulatory Strategy Group 2, Regulatory Affairs
  • Pfizer R&D Japan G.K., Japan

Contact us